Bioinformatics studies on sequence, structure and functional relationships of proteins involved in the complement system

The complement system consists of -30 proteins involved in a series of cascading reactions ultimately resulting in the destruction of invading pathogens. Central to the pathway are three paralogous proteins, C3, C4 and C5. Furthermore, pivotal to the successful functioning of this system are five proteins belonging to the regulators of complement activation (RCA) family they ensure that a complement-mediated immune response is proportionate and targeted against infection. RCA proteins are characterised by numerous occurrences of a single module-type; the complement control protein (CCP) module. In this work, comprehensive bioinformatics analyses of sequence and structure of CCP modules was undertaken. Through extensive database and literature searches CCP module sequences and structures were retrieved and large-scale all-against-all sequence and structure comparisons performed; analysis of intermodular orientations for pairs of modules and larger fragments was performed. These analyses revealed interesting consensus and novel trends. Based upon optimal use of experimentally determined CCP module structures as templates, an automated large-scale protein structure comparative modelling procedure was implemented for a set of 203 CCPmodule sequences. The accuracies of models produced were validated, and the models are publicly available online at "The CCP module model database" (http://www.bru.ed.ac.uk/—dinesh/ccp-db.html), which also serves as a comprehensive resource for information on CCP modules. By way of example, surface electrostatic analyses were undertaken for the first 28 CCP module models of complement receptor type 1 (CR1). This revealed a striking case of adaptive evolution assignments to clusters based on surfaces differ from assignments to clusters based on sequences and sheds light on mutagenesis studies. Overall, the models provide a rich vein of information for design of mutants, interpretation of phenotypic consequences of polymorphisms, and prediction of function. This wider utility of models is discussed in relation to inferring consequences of several disease-associated sequence variations for complement proteins CR1, factor H, MCP, and another CCP-containing protein, SRPX2. Finally, homology models of CS and C5b were created on the basis of the recent landmark publication of C3 and C3b structures. This revealed presence of a novel

[1]  R A Sayle,et al.  RASMOL: biomolecular graphics for all. , 1995, Trends in biochemical sciences.

[2]  V. Nussenzweig,et al.  Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes , 1982, The Journal of experimental medicine.

[3]  R. Wade,et al.  Classification of protein sequences by homology modeling and quantitative analysis of electrostatic similarity , 1999, Proteins.

[4]  D. Lublin,et al.  Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. , 1996, Journal of immunology.

[5]  B. F. Hall,et al.  CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. , 1989, Journal of immunology.

[6]  H. E. Gilbert,et al.  The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions. , 2006, Journal of molecular biology.

[7]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[8]  J. D. The Human Factor , 2022 .

[9]  G. Ambrus,et al.  A True Autoactivating Enzyme , 2005, Journal of Biological Chemistry.

[10]  T L Blundell,et al.  An evaluation of the performance of an automated procedure for comparative modelling of protein tertiary structure. , 1993, Protein engineering.

[11]  Marie-Noëlle Metz-Lutz,et al.  SRPX2 mutations in disorders of language cortex and cognition. , 2006, Human molecular genetics.

[12]  Ian A Wilson,et al.  Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Ariga,et al.  Diversity of Sites for Measles Virus Binding and for Inactivation of Complement C3b and C4b on Membrane Cofactor Protein CD46 (*) , 1995, The Journal of Biological Chemistry.

[14]  J. Lambris,et al.  A 34-amino acid peptide of the third component of complement mediates properdin binding. , 1988, Journal of immunology.

[15]  A. Blom,et al.  CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. , 2003, Molecular immunology.

[16]  L. Presta,et al.  Identification of an E-selectin region critical for carbohydrate recognition and cell adhesion [published erratum appears in J Cell Biol 1993 Feb;120(4):1071] , 1992, The Journal of cell biology.

[17]  John D Lambris,et al.  Solvent Accessibility of Native and Hydrolyzed Human Complement Protein 3 Analyzed by Hydrogen/Deuterium Exchange and Mass Spectrometry 1 , 2005, The Journal of Immunology.

[18]  G. Lindahl,et al.  Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. , 1995, Journal of immunology.

[19]  P. Barlow,et al.  Dissecting Sites Important for Complement Regulatory Activity in Membrane Cofactor Protein (MCP; CD46)* , 2000, The Journal of Biological Chemistry.

[20]  Gerald J. Wyckoff,et al.  Rapid evolution of male reproductive genes in the descent of man , 2000, Nature.

[21]  Chuong-Thu Thai,et al.  Complement Components C5 and C7: Recombinant Factor I Modules of C7 Bind to the C345C Domain of C51 , 2004, The Journal of Immunology.

[22]  Lin Wei,et al.  Impact of the SpeB Protease on Binding of the Complement Regulatory Proteins Factor H and Factor H-Like Protein 1 by Streptococcus pyogenes , 2005, Infection and Immunity.

[23]  Steven E. Brenner,et al.  WebLogo: A sequence logo generator - eScholarship , 2004 .

[24]  U. Schaible,et al.  Borrelia Burgdorferi Infection in Mice: Aspects of Inflammation and Immune Responses , 1994 .

[25]  Crystallization of human complement component C5. , 1998, Acta crystallographica. Section D, Biological crystallography.

[26]  W R Taylor,et al.  Homology modelling by distance geometry. , 1996, Folding & design.

[27]  N. Grishin,et al.  Structural classification of small, disulfide-rich protein domains. , 2006, Journal of molecular biology.

[28]  D. Pérez-Caballero,et al.  Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. , 2002, American journal of human genetics.

[29]  D. Gerlier,et al.  Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus , 1993, Journal of virology.

[30]  W. Baldwin,et al.  Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). , 1999, Molecular immunology.

[31]  P. Zipfel,et al.  Mapping of the adrenomedullin-binding domains in human complement factor H. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[32]  G. Remuzzi,et al.  Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. , 2003, Human molecular genetics.

[33]  B. Dahlbäck,et al.  High affinity binding of human vitamin K-dependent protein S to a truncated recombinant beta-chain of C4b-binding protein expressed in Escherichia coli. , 1993, The Journal of biological chemistry.

[34]  P. Zipfel,et al.  Further Characterization of Complement Regulator-Acquiring Surface Proteins of Borrelia burgdorferi , 2001, Infection and Immunity.

[35]  J. Winkelstein,et al.  Soluble human complement receptor type 1 inhibits complement-mediated host defense. , 1994, Clinical and diagnostic laboratory immunology.

[36]  R. Battistutta,et al.  Structure at 1.44 A resolution of an N-terminally truncated form of the rat serum complement C3d fragment. , 2000, Biochimica et biophysica acta.

[37]  R. Ogata,et al.  Active sites in complement component C3 mapped by mutations at indels. , 1998, Journal of immunology.

[38]  P. Zipfel,et al.  FHR-1, an additional human plasma protein, binds to complement regulator-acquiring surface proteins of Borrelia burgdorferi , 2008 .

[39]  R. Campbell,et al.  Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. , 1986, The EMBO journal.

[40]  J. Jensenius,et al.  Complement Receptor 1/Cd35 Is a Receptor for Mannan-Binding Lectin , 2000, The Journal of experimental medicine.

[41]  P. Bork,et al.  Protein domain analysis in the era of complete genomes , 2002, FEBS letters.

[42]  D. Fearon,et al.  Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins , 1987, The Journal of experimental medicine.

[43]  W. Wooster,et al.  Crystal structure of , 2005 .

[44]  A Godzik,et al.  Surface map comparison: studying function diversity of homologous proteins. , 2001, Journal of molecular biology.

[45]  W. Gray,et al.  Third component of human complement: localization of the internal thiolester bond. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Discipio,et al.  Function of the factor I modules (FIMS) of human complement component C6. , 1998, The Journal of biological chemistry.

[47]  B. Morgan,et al.  Pigs Express Multiple Forms of Decay-Accelerating Factor (CD55), All of Which Contain Only Three Short Consensus Repeats1 , 2000, The Journal of Immunology.

[48]  Yuzuru Suzuki,et al.  Regulator of complement activation (RCA) gene cluster in Xenopus tropicalis , 2009, Immunogenetics.

[49]  V. Holers,et al.  Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. , 2007, Molecular immunology.

[50]  P Rotkiewicz,et al.  Generalized comparative modeling (GENECOMP): A combination of sequence comparison, threading, and lattice modeling for protein structure prediction and refinement , 2001, Proteins.

[51]  M. Grainger,et al.  A novel Sushi domain-containing protein of Plasmodium falciparum. , 2005, Molecular and biochemical parasitology.

[52]  Hans Neurath,et al.  The Kinemage: A tool for scientific communication , 1996 .

[53]  T. Stehle,et al.  The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d binding , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Blom,et al.  Localization of a Hydrophobic Binding Site for Anticoagulant Protein S on the β-Chain of Complement Regulator C4b-binding Protein* , 2001, The Journal of Biological Chemistry.

[55]  R. Jacobson,et al.  Measles virus receptors: SLAM and CD46 , 2004, Reviews in medical virology.

[56]  H. Müller-Eberhard,et al.  The membrane attack complex of complement. , 1986, Annual review of immunology.

[57]  G. Hageman,et al.  Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.

[58]  J. Lambris,et al.  Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Open Reading Frame 4 Protein (Kaposica) Is a Functional Homolog of Complement Control Proteins , 2003, Journal of Virology.

[59]  Elisa Leung,et al.  The complement regulator C4b-binding protein (C4BP) interacts with both the C4c and C4dg subfragments of the parent C4b ligand: evidence for synergy in C4BP subsite binding. , 2006, Biochemistry.

[60]  Timothy S Baker,et al.  Structure of decay-accelerating factor bound to echovirus 7: A virus-receptor complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Oppermann,et al.  The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. , 1999, Molecular immunology.

[62]  G. Remuzzi,et al.  The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. , 2001, Journal of the American Society of Nephrology : JASN.

[63]  E. Verrier,et al.  Pexelizumab – a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass , 2005, Expert opinion on biological therapy.

[64]  G. Ball,et al.  Human C4b-binding Protein, Structural Basis for Interaction with Streptococcal M Protein, a Major Bacterial Virulence Factor* , 2006, Journal of Biological Chemistry.

[65]  R. Huber,et al.  Crystal structure analysis and molecular model of human C3a anaphylatoxin. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[66]  W. Fridman,et al.  Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome , 2004, Journal of Medical Genetics.

[67]  R. Marconi,et al.  Demonstration of Factor H-Like Protein 1 Binding to Treponema denticola, a Pathogen Associated with Periodontal Disease in Humans , 2005, Infection and Immunity.

[68]  R C Wade,et al.  MolSurfer: two-dimensional maps for navigating three-dimensional structures of proteins. , 1999, Trends in biochemical sciences.

[69]  C. Mold,et al.  Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. , 1996, Journal of immunology.

[70]  W. Burgdorfer,et al.  Relapsing fever spirochetes: an aberrant strain of Borrelia parkeri from Oregon. , 1955, Experimental parasitology.

[71]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[72]  J. Atkinson,et al.  Synergy between Two Active Sites of Human Complement Receptor Type 1 (CD35) in Complement Regulation: Implications for the Structure of the Classical Pathway C3 Convertase and Generation of More Potent Inhibitors1 , 2005, The Journal of Immunology.

[73]  J. Krushkal,et al.  Evolutionary history of orthopoxvirus proteins similar to human complement regulators , 2005, Gene.

[74]  R Sánchez,et al.  Advances in comparative protein-structure modelling. , 1997, Current opinion in structural biology.

[75]  H. Okada,et al.  Alternative exon usage in the 3′ region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor , 2000, Immunogenetics.

[76]  A. Blom,et al.  Bordetella pertussis binds to human C4b‐binding protein (C4BP) at a site similar to that used by the natural ligand C4b , 2001, European journal of immunology.

[77]  Haino,et al.  Structural characterization of mouse CD97 and study of its specific interaction with the murine decay‐accelerating factor (DAF, CD55) , 1999, Immunology.

[78]  B. Fleckenstein,et al.  New member of the multigene family of complement control proteins in herpesvirus saimiri , 1992, Journal of virology.

[79]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[80]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[81]  E. Levashina,et al.  Thioester-containing proteins and insect immunity. , 2004, Molecular immunology.

[82]  Sean R. Eddy,et al.  Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids , 1998 .

[83]  Christopher D. Richardson,et al.  The human CD46 molecule is a receptor for measles virus (Edmonston strain) , 1993, Cell.

[84]  J. Atkinson,et al.  Evolution of the complement system. , 1991, Immunology today.

[85]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[86]  W Reichardt,et al.  Streptococcus pyogenes. , 2001, Contributions to microbiology.

[87]  A. Lesk,et al.  The relation between the divergence of sequence and structure in proteins. , 1986, The EMBO journal.

[88]  I. Gigli,et al.  Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. , 2000, Molecular biology and evolution.

[89]  K. Christopher Garcia,et al.  The Structure of Interleukin-2 Complexed with Its Alpha Receptor , 2005, Science.

[90]  W. Grabarse,et al.  Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. , 2002, Structure.

[91]  B. Dahlbäck,et al.  Serum Amyloid P Component Binding to C4b-binding Protein (*) , 1995, The Journal of Biological Chemistry.

[92]  U. Ryan,et al.  Soluble Human Complement Receptor 1 Limits Ischemic Damage in Cardiac Surgery Patients at High Risk Requiring Cardiopulmonary Bypass , 2004, Circulation.

[93]  C. Sander,et al.  Quality control of protein models : directional atomic contact analysis , 1993 .

[94]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[95]  J. Grötzinger,et al.  The Structure of the Interleukin-15α Receptor and Its Implications for Ligand Binding* , 2006, Journal of Biological Chemistry.

[96]  D. Soares,et al.  Complement Control Protein Modules in the Regulators of Complement Activation , 2005 .

[97]  R. Pierson,et al.  Hyperacute Lung Rejection in the Pig-to-Human Model 4: Evidence for Complement and Antibody Independent Mechanisms , 2005, Transplantation.

[98]  S. Čučnik,et al.  Avidity of anti-beta-2-glycoprotein I antibodies. , 2005, Autoimmunity reviews.

[99]  The human C4b-binding protein beta-chain gene. , 1993, The Journal of biological chemistry.

[100]  R. Ogata,et al.  Distal Recognition Site for Classical Pathway Convertase Located in the C345C/Netrin Module of Complement Component C51 , 2000, The Journal of Immunology.

[101]  S. Carroll,et al.  Genome-scale approaches to resolving incongruence in molecular phylogenies , 2003, Nature.

[102]  András Fiser,et al.  Molecular Biophysics , 2022 .

[103]  Piet Gros,et al.  Structures of complement component C3 provide insights into the function and evolution of immunity , 2005, Nature.

[104]  D. Pérez-Caballero,et al.  Interaction between Complement Regulators and Streptococcus pyogenes: Binding of C4b-Binding Protein and Factor H/Factor H-Like Protein 1 to M18 Strains Involves Two Different Cell Surface Molecules1 , 2004, The Journal of Immunology.

[105]  B. Palanca,et al.  A critical role for murine complement regulator crry in fetomaternal tolerance. , 2000, Science.

[106]  M. Kirkitadze,et al.  Structure and flexibility of the multiple domain proteins that regulate complement activation , 2001, Immunological reviews.

[107]  V. Holers,et al.  CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. , 1994, Journal of immunology.

[108]  M. Telen,et al.  Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. , 1991, Journal of immunology.

[109]  B. Nagar,et al.  X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. , 1998, Science.

[110]  B. Stevenson,et al.  Differential Binding of Host Complement Inhibitor Factor H by Borrelia burgdorferi Erp Surface Proteins: a Possible Mechanism Underlying the Expansive Host Range of Lyme Disease Spirochetes , 2002, Infection and Immunity.

[111]  J. Atkinson,et al.  Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria , 1997, Molecular microbiology.

[112]  S. Antonarakis,et al.  Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[113]  Maria Jesus Martin,et al.  The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..

[114]  L. Klickstein,et al.  Complement receptor type 1 (CR1, CD35) is a receptor for C1q. , 1997, Immunity.

[115]  K. Chou,et al.  Prediction of the Tertiary Structure of the Complement Control Protein Module , 1997, Journal of protein chemistry.

[116]  A. Gaggar,et al.  CD46 is a cellular receptor for group B adenoviruses , 2003, Nature Medicine.

[117]  D. Hourcade,et al.  Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[118]  R. Smith,et al.  Targeting anticomplement agents. , 2002, Biochemical Society transactions.

[119]  R. Bollinger,et al.  The effect of soluble complement receptor type 1 on hyperacute allograft rejection. , 1991, The Journal of surgical research.

[120]  Robert B Sim,et al.  Purification and structural studies on the complement-system control protein beta 1H (Factor H). , 1982, The Biochemical journal.

[121]  M. Kaplan Eculizumab (Alexion). , 2002, Current opinion in investigational drugs.

[122]  A. Sali,et al.  Protein Structure Prediction and Structural Genomics , 2001, Science.

[123]  M. Pangburn,et al.  Disease-associated sequence variations in factor H: a structural biology approach. , 2006, Advances in experimental medicine and biology.

[124]  M. Shoham,et al.  Molecular modeling and mechanism of action of human decay-accelerating factor. , 1996, Protein engineering.

[125]  J. Atkinson,et al.  Structure of the gene for human complement protein decay accelerating factor. , 1990, Journal of immunology.

[126]  T. Horan,et al.  CSMD1 Is a Novel Multiple Domain Complement-Regulatory Protein Highly Expressed in the Central Nervous System and Epithelial Tissues1 , 2006, The Journal of Immunology.

[127]  Binding of Complement Factor H to Loop 5 of Porin Protein 1A: A Molecular Mechanism of Serum Resistance of Nonsialylated Neisseria gonorrhoeae , 1998 .

[128]  Roland L. Dunbrack,et al.  Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. , 1997, Journal of molecular biology.

[129]  A. Day,et al.  Structure-function relationships of the complement components. , 1989, Immunology today.

[130]  J. Atkinson,et al.  Human complement receptor type 1 (CR1) binds to a major malarial adhesin. , 2002, Trends in molecular medicine.

[131]  L. McDaniel,et al.  In vivo binding of complement regulator factor H by Streptococcus pneumoniae. , 2005, The Journal of infectious diseases.

[132]  E. Johnsson,et al.  Human complement regulators: a major target for pathogenic microorganisms. , 2000, Current opinion in immunology.

[133]  D. Lipman,et al.  Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[134]  M. Billeter,et al.  Comparison of protein structures determined by NMR in solution and by X-ray diffraction in single crystals , 1992, Quarterly Reviews of Biophysics.

[135]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[136]  K. Toyoshima,et al.  A Novel Chicken Membrane-Associated Complement Regulatory Protein: Molecular Cloning and Functional Characterization1 , 2001, The Journal of Immunology.

[137]  S. Čučnik,et al.  High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome , 2004, Annals of the rheumatic diseases.

[138]  Opportunities for New Therapies Based on the Natural Regulators of Complement Activation , 2005, Annals of the New York Academy of Sciences.

[139]  R. Peek,et al.  The Role of Decay-accelerating Factor as a Receptor for Helicobacter pylori and a Mediator of Gastric Inflammation*♦ , 2006, Journal of Biological Chemistry.

[140]  S. Rodríguez de Córdoba,et al.  The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.

[141]  T. Meri,et al.  Complement Evasion by Borrelia burgdorferi: Serum-Resistant Strains Promote C3b Inactivation , 2001, Infection and Immunity.

[142]  H. Lior,et al.  Haemolytic-uraemic syndrome , 1994, The Lancet.

[143]  C. Sander,et al.  Errors in protein structures , 1996, Nature.

[144]  K. Garcia,et al.  Structure of the Quaternary Complex of Interleukin-2 with Its α, ß, and γc Receptors , 2005, Science.

[145]  Pnur BnlqN Moonn,et al.  Solution of the Structure , 2007 .

[146]  M. Marques,et al.  Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation. , 2004, American journal of clinical pathology.

[147]  Christine Gaboriaud,et al.  The Crystal Structure of the Globular Head of Complement Protein C1q Provides a Basis for Its Versatile Recognition Properties* , 2003, Journal of Biological Chemistry.

[148]  R. Campbell,et al.  Internal homologies of the Ba fragment from human complement component Factor B, a class III MHC antigen. , 1984, The EMBO journal.

[149]  Ruth Nussinov,et al.  A method for simultaneous alignment of multiple protein structures , 2004, Proteins.

[150]  G. Remuzzi,et al.  Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement. , 2005, Journal of the American Society of Nephrology : JASN.

[151]  John D Lambris,et al.  Complement diversity: a mechanism for generating immune diversity? , 1998, Immunology today.

[152]  I. Campbell,et al.  Solution structure of a pair of complement modules by nuclear magnetic resonance. , 1993, Journal of molecular biology.

[153]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.

[154]  P. Lusso,et al.  Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function* , 2002, The Journal of Biological Chemistry.

[155]  D. Marion,et al.  Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family. , 1998, Biochemistry.

[156]  A. Blom,et al.  A Cluster of Positively Charged Amino Acids in the C4BP α-Chain Is Crucial for C4b Binding and Factor I Cofactor Function* , 1999, The Journal of Biological Chemistry.

[157]  F. Cohen,et al.  An evolutionary trace method defines binding surfaces common to protein families. , 1996, Journal of molecular biology.

[158]  P. Zipfel,et al.  Recruitment of Complement Factor H-Like Protein 1 Promotes Intracellular Invasion by Group A Streptococci , 2003, Infection and Immunity.

[159]  D. Uhrín,et al.  Functional Insights from the Structure of the Multifunctional C345C Domain of C5 of Complement* , 2005, Journal of Biological Chemistry.

[160]  T. L. Blundell,et al.  Knowledge-based prediction of protein structures and the design of novel molecules , 1987, Nature.

[161]  G. Cornelis,et al.  Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules , 1993, Infection and immunity.

[162]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[163]  R. Doolittle,et al.  Progressive sequence alignment as a prerequisitetto correct phylogenetic trees , 2007, Journal of Molecular Evolution.

[164]  D. Cue,et al.  Acquisition of Regulators of Complement Activation by Streptococcus pyogenes Serotype M1 , 2002, Infection and Immunity.

[165]  D. Isenman,et al.  Identification of Residues within the 727–767 Segment of Human Complement Component C3 Important for Its Interaction with Factor H and with Complement Receptor 1 (CR1, CD35)* , 1999, The Journal of Biological Chemistry.

[166]  A. Buil,et al.  Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. , 2005, Human molecular genetics.

[167]  Brian O. Smith,et al.  Structural Analysis of the Complement Control Protein (CCP) Modules of GABAB Receptor 1a , 2004, Journal of Biological Chemistry.

[168]  R. Liddington,et al.  Crystal structure of the A domain from complement factor B reveals an integrin-like open conformation. , 2004, Structure.

[169]  C. Smith,et al.  The activation of human complement component C5 by a fluid phase C5 convertase. , 1983, The Journal of biological chemistry.

[170]  Wei Ling Lau,et al.  Identification of two new members of the CSMD gene family. , 2003, Genomics.

[171]  P. Lachmann,et al.  Novel cleavage products of the third component of human complement. , 1980, Molecular immunology.

[172]  H. Okada,et al.  Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing. , 1995, Journal of immunology.

[173]  R. Frade,et al.  Evidence for a new transcript of the Epstein-Barr virus/C3d receptor (CR2, CD21) which is due to alternative exon usage. , 1998, Molecular immunology.

[174]  N. C. Price,et al.  Co‐operativity between modules within a C3b‐binding site of complement receptor type 1 , 1999, FEBS letters.

[175]  J. Atkinson,et al.  Mutations in CD46, a complement regulatory protein, predispose to atypical HUS. , 2004, Trends in molecular medicine.

[176]  S. Rodríguez de Córdoba,et al.  Physical linkage of the human genes coding for complement factor H and coagulation factor XIII B subunit. , 1990, Genomics.

[177]  Adrian A Canutescu,et al.  Access the most recent version at doi: 10.1110/ps.03154503 References , 2003 .

[178]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[179]  C. Smith,et al.  Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[180]  B. Moss,et al.  Inhibition of the complement cascade by the major secretory protein of vaccinia virus. , 1990, Science.

[181]  A. Oldstone Molecular Mimicry , 1989, Current Topics in Microbiology and Immunology.

[182]  J. Atkinson,et al.  Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. , 1994, The Journal of biological chemistry.

[183]  E. Zuiderweg,et al.  Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. , 1989, Biochemistry.

[184]  A. Mizota,et al.  Complement factor H polymorphisms in Japanese population with age-related macular degeneration. , 2006, Molecular vision.

[185]  P. Hass,et al.  Structure of C3b in complex with CRIg gives insights into regulation of complement activation , 2006, Nature.

[186]  E. Souied,et al.  Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. , 2005, Molecular vision.

[187]  J. Atkinson,et al.  Structure–function relationships of complement receptor type 1 , 2001, Immunological reviews.

[188]  Werner Braun,et al.  Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules , 1998, J. Comput. Chem..

[189]  A. Blom,et al.  Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus* , 2003, The Journal of Biological Chemistry.

[190]  D. Hourcade,et al.  Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein , 1995, The Journal of experimental medicine.

[191]  E. Hawrot,et al.  The metabotropic GABA receptor: molecular insights and their functional consequences , 2000, Cellular and Molecular Life Sciences CMLS.

[192]  G. Nemerow,et al.  Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[193]  I. Campbell,et al.  Fibronectin structure and assembly. , 1994, Current opinion in cell biology.

[194]  Dirk Walther,et al.  MolSurfer: a macromolecular interface navigator , 2003, Nucleic Acids Res..

[195]  K. Bromek,et al.  Structure of the C3b Binding Site of CR1 (CD35), the Immune Adherence Receptor , 2002, Cell.

[196]  T. Meri,et al.  Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis , 2005, European journal of immunology.

[197]  S. Christensen,et al.  The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. , 1990, Journal of immunology.

[198]  P Bork,et al.  Structure and distribution of modules in extracellular proteins , 1996, Quarterly Reviews of Biophysics.

[199]  A. Egorov,et al.  A study of the structure of human M-globulin subunits by maleation. , 1971, Immunochemistry.

[200]  Thomas Walz,et al.  Structural transitions of complement component C3 and its activation products , 2006, Proceedings of the National Academy of Sciences.

[201]  Ching-Yu Cheng,et al.  Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. , 2006, Investigative ophthalmology & visual science.

[202]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[203]  V. Michael Holers,et al.  Structure of Complement Receptor 2 in Complex with Its C3d Ligand , 2001, Science.

[204]  L. McDaniel,et al.  Interaction of human factor H with PspC of Streptococcus pneumoniae. , 2004, The Indian journal of medical research.

[205]  Anton Nekrutenko,et al.  Signatures of domain shuffling in the human genome. , 2002, Genome research.

[206]  Michael Schroeder,et al.  SCOPPI: a structural classification of protein–protein interfaces , 2005, Nucleic Acids Res..

[207]  T. Goodship Inherited dysregulation of the complement system. , 2004, Bulletin et memoires de l'Academie royale de medecine de Belgique.

[208]  R. Cramer,et al.  Validation of the general purpose tripos 5.2 force field , 1989 .

[209]  S. Minoshima,et al.  A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1. , 2003, Biochemical and biophysical research communications.

[210]  A. Sali,et al.  Large-scale protein structure modeling of the Saccharomyces cerevisiae genome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[211]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[212]  C. M. Fletcher,et al.  Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. , 1994, Structure.

[213]  T. Seya,et al.  Regulator of Complement Activation (RCA) Locus in Chicken: Identification of Chicken RCA Gene Cluster and Functional RCA Proteins1 , 2005, The Journal of Immunology.

[214]  Aidan Budd,et al.  Bacterial α2-macroglobulins: colonization factors acquired by horizontal gene transfer from the metazoan genome? , 2004, Genome Biology.

[215]  E. Davie,et al.  Structure of transglutaminases. , 1990, The Journal of biological chemistry.

[216]  W. Wong,et al.  Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. , 1993, Journal of immunology.

[217]  滝沢 壽男 Complement inhibitor of rat cell membrane resembling mouse Crry/p65 , 1995 .

[218]  O. Doumbo,et al.  Expansion of the Knops blood group system and subdivision of Sla , 2002, Transfusion.

[219]  J. Atkinson,et al.  Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. , 1997, Virology.

[220]  Peer Bork,et al.  SMART 4.0: towards genomic data integration , 2004, Nucleic Acids Res..

[221]  D. Hochstrasser,et al.  The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences , 1993, Electrophoresis.

[222]  W. Baldwin,et al.  Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. , 1997, Transplantation.

[223]  B. Dahlbäck,et al.  The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function. , 1997, The Biochemical journal.

[224]  M. Kirkitadze,et al.  Independently melting modules and highly structured intermodular junctions within complement receptor type 1. , 1999, Biochemistry.

[225]  Robert B Sim,et al.  Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. , 1997, Journal of immunology.

[226]  C. Newbold,et al.  Mapping of the Region of Complement Receptor (CR) 1 Required for Plasmodium falciparum Rosetting and Demonstration of the Importance of CR1 in Rosetting in Field Isolates1 , 2000, The Journal of Immunology.

[227]  J. Marx Genetics. A clearer view of macular degeneration. , 2006, Science.

[228]  K. Murthy,et al.  Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[229]  D. Benayahu,et al.  Molecular and cellular characterization of SEL‐OB/SVEP1 in osteogenic cells in vivo and in vitro , 2006, Journal of cellular physiology.

[230]  S. Richards,et al.  Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. , 2004, The New England journal of medicine.

[231]  B. Bradt,et al.  Murine C4b-binding protein. Mapping of the ligand binding site and the N-terminus of the pre-protein. , 1993, Journal of immunology.

[232]  D. Pérez-Caballero,et al.  Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. , 2001, American journal of human genetics.

[233]  Piet Gros,et al.  Structure of C3b reveals conformational changes that underlie complement activity , 2006, Nature.

[234]  R. Ogata,et al.  Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family. , 1999, Journal of immunology.

[235]  J. Parkinson,et al.  Large-scale modelling as a route to multiple surface comparisons of the CCP module family. , 2005, Protein engineering, design & selection : PEDS.

[236]  I. Campbell,et al.  NMR studies of a viral protein that mimics the regulators of complement activation. , 1997, Journal of molecular biology.

[237]  T. Kawai,et al.  Outer membrane protein 100, a versatile virulence factor of Actinobacillus actinomycetemcomitans , 2003, Molecular microbiology.

[238]  J. Lambris,et al.  A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. , 1988, The Journal of biological chemistry.

[239]  B. Morgan,et al.  Complement therapeutics; history and current progress. , 2003, Molecular immunology.

[240]  J. Collins,et al.  Significance of protein sequence similarities. , 1990, Methods in enzymology.

[241]  S. Ranganathan,et al.  A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. , 2000, European Journal of Immunology.

[242]  Peer Bork,et al.  Recent improvements to the SMART domain-based sequence annotation resource , 2002, Nucleic Acids Res..

[243]  C. Mold,et al.  Structure/function studies of human decay‐accelerating factor , 2000, Immunology.

[244]  P. Tommila,et al.  Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population. , 2006, Molecular vision.

[245]  J. Greer Comparative modeling methods: Application to the family of the mammalian serine proteases , 1990, Proteins.

[246]  Ruth Nussinov,et al.  MultiProt - A Multiple Protein Structural Alignment Algorithm , 2002, WABI.

[247]  J. Goodship,et al.  Genetic studies into inherited and sporadic hemolytic uremic syndrome. , 1998, Kidney international.

[248]  J. Nyborg,et al.  The structure of bovine complement component 3 reveals the basis for thioester function. , 2006, Journal of molecular biology.

[249]  Dimitrios Morikis,et al.  Studies of Structure-Activity Relations of Complement Inhibitor Compstatin 1 , 2003 .

[250]  V. Fischetti,et al.  Identification of the Streptococcal M Protein Binding Site on Membrane Cofactor Protein (CD46)1 , 2002, The Journal of Immunology.

[251]  P. Zipfel,et al.  An interactive web database of factor H‐associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease‐associated mutations , 2006, Human mutation.

[252]  J. Goodship,et al.  Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[253]  Frcp C. Mark Taylor Hemolytic-Uremic Syndrome and Complement Factor H Deficiency: Clinical Aspects , 2001, Seminars in thrombosis and hemostasis.

[254]  B. Rost Twilight zone of protein sequence alignments. , 1999, Protein engineering.

[255]  J. Parma,et al.  Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. , 1998, The New England journal of medicine.

[256]  M. Carroll,et al.  The complement system in B cell regulation. , 2004, Molecular immunology.

[257]  J. Goodship,et al.  Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. , 2001, American journal of human genetics.

[258]  M. L. Le Beau,et al.  Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins , 1988, The Journal of experimental medicine.

[259]  Katherine A. Oehlberg,et al.  Variola virus immune evasion proteins. , 2003, Microbes and infection.

[260]  B. Paul Morgan,et al.  Molecular Dissection of Interactions between Components of the Alternative Pathway of Complement and Decay Accelerating Factor (CD55)* , 2005, Journal of Biological Chemistry.

[261]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[262]  J. Atkinson,et al.  Structure-Function Analysis of the Active Sites of Complement Receptor Type 1* , 1998, The Journal of Biological Chemistry.

[263]  A. Blom,et al.  Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase. , 2000, Molecular immunology.

[264]  Didier Raoult,et al.  Molecular identification by , 2000 .

[265]  J. Moulds A review of the Knops blood group: separating fact from fallacy , 2002, Immunohematology.

[266]  L. Jorde,et al.  Duplication and divergence in humans and chimpanzees , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[267]  M. Levitt Accurate modeling of protein conformation by automatic segment matching. , 1992, Journal of molecular biology.

[268]  D. Gerlier,et al.  CD46 (membrane cofactor protein) associates with multiple β1 integrins and tetraspans , 2000, European journal of immunology.

[269]  David T. Williams,et al.  Structural and Functional Insights into the Interaction of Echoviruses and Decay-accelerating Factor* , 2006, Journal of Biological Chemistry.

[270]  K. Murthy,et al.  RETRACTED: Crystal Structure of a Complement Control Protein that Regulates Both Pathways of Complement Activation and Binds Heparan Sulfate Proteoglycans , 2001, Cell.

[271]  Nathan A. Baker,et al.  PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..

[272]  D. Hourcade,et al.  Decay Accelerating Activity of Complement Receptor Type 1 (CD35) , 1999, The Journal of Biological Chemistry.

[273]  J. Hamann,et al.  The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF) , 1997 .

[274]  J. Atkinson,et al.  Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence , 2001, Cellular microbiology.

[275]  M. Mizuno,et al.  The possibilities and pitfalls for anti-complement therapies in inflammatory diseases. , 2004, Current drug targets. Inflammation and allergy.

[276]  I. Campbell,et al.  Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. , 1992, Biochemistry.

[277]  R C Wade,et al.  Species dependence of enzyme‐substrate encounter rates for triose phosphate isomerases , 1998, Proteins.

[278]  D. Lublin,et al.  Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding , 1995, Journal of virology.

[279]  P Lukacik,et al.  Complement regulation at the molecular level: the structure of decay-accelerating factor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[280]  J. Fontecilla-Camps,et al.  THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R , 2002 .

[281]  E. Johnsson,et al.  Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. , 1998, Journal of immunology.

[282]  G. D. Ross,et al.  Membrane complement receptors specific for bound fragments of C3. , 1985, Advances in immunology.

[283]  Zhiping Nie,et al.  Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[284]  Arne Elofsson,et al.  All are not equal: A benchmark of different homology modeling programs , 2005, Protein science : a publication of the Protein Society.

[285]  P. Berggren,et al.  Cell Signaling by the Type IV Pili of Pathogenic Neisseria* , 1998, The Journal of Biological Chemistry.

[286]  Edwin M Stone,et al.  Macular degeneration. , 2007, Annual review of medicine.

[287]  D. Fearon,et al.  Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis , 1988, The Journal of experimental medicine.

[288]  A. Sahu,et al.  Identification of Complement Regulatory Domains in Vaccinia Virus Complement Control Protein , 2005, Journal of Virology.

[289]  M. Pangburn,et al.  Native conformations of human complement components C3 and C4 show different dependencies on thioester formation. , 1998, The Biochemical journal.

[290]  K. Murthy,et al.  Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance. , 2003, Biochimica et biophysica acta.

[291]  D. Higgins,et al.  T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.

[292]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[293]  S. Meri,et al.  The factor H protein family. , 1999, Immunopharmacology.

[294]  S. Narayana,et al.  Crystal Structure of a Complement Factor D Mutant Expressing Enhanced Catalytic Activity (*) , 1995, The Journal of Biological Chemistry.

[295]  T. Woodruff,et al.  Increased Potency of a Novel Complement Factor 5a Receptor Antagonist in a Rat Model of Inflammatory Bowel Disease , 2005, Journal of Pharmacology and Experimental Therapeutics.

[296]  J. Bergelson,et al.  Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55) , 1995, Journal of virology.

[297]  D. Birmingham,et al.  CR1 and CR1‐like: the primate immune adherence receptors , 2001, Immunological reviews.

[298]  L. Giudice,et al.  Cell surface adhesion of pregnancy-associated plasma protein-A is mediated by four clusters of basic residues located in its third and fourth CCP module. , 2004, European journal of biochemistry.

[299]  G. Ambrus,et al.  The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions. , 2004, Journal of molecular biology.

[300]  S. Wodak,et al.  Modelling the polypeptide backbone with 'spare parts' from known protein structures. , 1989, Protein engineering.

[301]  Philipp E. Scherer,et al.  The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor , 1998, Current Biology.

[302]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[303]  Jürgen Brickmann,et al.  A new approach to analysis and display of local lipophilicity/hydrophilicity mapped on molecular surfaces , 1993, J. Comput. Aided Mol. Des..

[304]  H. Willison,et al.  Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome , 2005, Annals of neurology.

[305]  Peer Bork,et al.  SMART, a simple modular architecture research tool , 1998 .

[306]  L. Kelley,et al.  An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. , 1996, Protein engineering.

[307]  P. Zipfel,et al.  Identification of the second heparin-binding domain in human complement factor H. , 1998, Journal of immunology.

[308]  Pietro Roversi,et al.  An atomic resolution model for assembly, architecture, and function of the Dr adhesins. , 2004, Molecular cell.

[309]  A. Blom,et al.  Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae , 2001 .

[310]  K. Bromek,et al.  Backbone dynamics of complement control protein (CCP) modules reveals mobility in binding surfaces , 2004, Protein science : a publication of the Protein Society.

[311]  J. Parkinson,et al.  Central modules of the vaccinia virus complement control protein are not in extensive contact. , 1999, The Biochemical journal.

[312]  M J Sternberg,et al.  Misleading local sequence alignments: implications for comparative protein modelling. , 1998, Protein engineering.

[313]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[314]  T L Blundell,et al.  Knowledge based modelling of homologous proteins, Part II: Rules for the conformations of substituted sidechains. , 1987, Protein engineering.

[315]  G. Remuzzi,et al.  Combined kidney and liver transplantation for familial haemolytic uraemic syndrome , 2002, The Lancet.

[316]  B. Bettler,et al.  Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. , 1997, Nature.

[317]  B. Dahlbäck,et al.  The Amino-terminal Module of the C4b-binding Protein β-Chain Contains the Protein S-binding Site* , 1996, The Journal of Biological Chemistry.

[318]  R. Ravelli,et al.  Adhesion mechanism of human β2‐glycoprotein I to phospholipids based on its crystal structure , 1999, The EMBO journal.

[319]  O. Spiller,et al.  Mapping CD55 Function , 2003, The Journal of Biological Chemistry.

[320]  M. Dierich,et al.  Role of complement in HIV infection. , 1997, Annual review of immunology.

[321]  E. A. Uvarova,et al.  Species-specific differences in the structure of orthopoxvirus complement-binding protein , 2001, Virus research.

[322]  D. Higgins,et al.  Multiple sequence alignments. , 2005, Current opinion in structural biology.

[323]  N. Ling,et al.  Localization of the heparin binding site of follistatin , 1992, Molecular and Cellular Endocrinology.

[324]  S. Shchelkunov,et al.  Conserved Surface-Exposed K/R-X-K/R Motifs and Net Positive Charge on Poxvirus Complement Control Proteins Serve as Putative Heparin Binding Sites and Contribute to Inhibition of Molecular Interactions with Human Endothelial Cells: a Novel Mechanism for Evasion of Host Defense , 2000, Journal of Virology.

[325]  P. A. Biro,et al.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[326]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[327]  R. Wetsel,et al.  Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity. , 1982, Journal of immunology.

[328]  J. Atkinson,et al.  Membrane cofactor protein. , 1992, Current topics in microbiology and immunology.

[329]  Kenneth M. Yamada,et al.  STRUCTURE AND FUNCTION OF FIBRONECTIN , 1982 .

[330]  P E Bourne,et al.  Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. , 1998, Protein engineering.